688163 賽倫生物
按盤價 
18.500 +2.010 (+12.189%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.961 | 3.513 | 8.610 | 23.029 | 20.010 |
| 總資產報酬率 ROA (%) | 2.859 | 3.379 | 8.181 | 21.393 | 18.656 |
| 投入資產回報率 ROIC (%) | 2.906 | 3.446 | 8.387 | 22.219 | 21.524 | 邊際利潤分析 |
| 銷售毛利率 (%) | 76.563 | 75.709 | 83.770 | 83.682 | 83.532 |
| 營業利潤率 (%) | 37.970 | 24.184 | 42.855 | 42.268 | 40.583 |
| 息稅前利潤/營業總收入 (%) | 36.851 | 22.672 | 40.964 | 41.803 | 39.241 |
| 淨利潤/營業總收入 (%) | 32.948 | 20.392 | 36.849 | 36.648 | 34.044 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 81.035 | 88.006 | 78.660 | 97.011 | 109.020 |
| 價值變動淨收益/利潤總額(%) | 17.084 | 22.756 | 21.667 | -0.896 | -7.143 |
| 營業外收支淨額/利潤總額(%) | -0.481 | -1.252 | -0.843 | -0.378 | -0.744 | 償債能力分析 |
| 流動比率 (X) | 52.152 | 37.979 | 37.104 | 14.050 | 12.026 |
| 速動比率 (X) | 49.770 | 36.188 | 35.075 | 11.263 | 8.700 |
| 資產負債率 (%) | 3.104 | 3.778 | 3.845 | 8.256 | 5.620 |
| 帶息債務/全部投入資本 (%) | 0.232 | 0.333 | 0.294 | 0.712 | -- |
| 股東權益/帶息債務 (%) | 42,351.304 | 29,465.780 | 33,387.045 | 13,386.062 | 9,068.029 |
| 股東權益/負債合計 (%) | 3,121.237 | 2,547.012 | 2,500.496 | 1,111.266 | 1,679.453 |
| 利息保障倍數 (X) | -39.319 | -18.689 | -26.735 | -137.029 | -37.639 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 75.366 | 28.697 | 17.841 | 11.392 | 0.000 |
| 存貨周轉天數 (天) | 343.048 | 386.922 | 660.221 | 522.744 | 0.000 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
